{"id":30005,"date":"2012-08-20T22:57:59","date_gmt":"2012-08-21T02:57:59","guid":{"rendered":"http:\/\/countingpips.com\/fx\/?p=30005"},"modified":"2012-08-20T22:58:00","modified_gmt":"2012-08-21T02:58:00","slug":"video-ipo-watch-regulus-therapeutics","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2012\/08\/20\/video-ipo-watch-regulus-therapeutics\/","title":{"rendered":"VIDEO: IPO Watch: Regulus Therapeutics"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><object id=\"GrabPlayer1767162\" width=\"542\" height=\"304\" type=\"application\/x-shockwave-flash\" align=\"middle\" data=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v44adff51aac4ceb851047983bb7254d8c1dc9b1d&#038;tgt=grabnetworks\"><param name=\"quality\" value=\"high\"\/><param name=\"allowScriptAccess\" value=\"always\"\/><param name=\"allowFullScreen\" value=\"true\"\/><param name=\"menu\" value=\"false\"\/><param name=\"wmode\" value=\"transparent\"\/><param name=\"movie\" value=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v44adff51aac4ceb851047983bb7254d8c1dc9b1d&#038;tgt=grabnetworks\"\/><\/object><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>Regulus Therapeutics, a biopharmaceutical company founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals (ISIS), announced today that it has filed a registration statement on Form S-1 with the SEC relating to a proposed IPO. All shares of the common stock to be sold in the offering will be offered by Regulus.<\/p>\n<p><img src='http:\/\/images.grab-media.com\/market_news\/2012\/08\/20\/ID201208IPO082012_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/images.grab-media.com\/market_news\/2012\/08\/20\/ID201208IPO082012_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regulus Therapeutics, a biopharmaceutical company founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals (ISIS), announced today that it has filed a registration statement on Form S-1 with the SEC relating to a proposed IPO. All shares of the common stock to be sold in the offering will be offered by Regulus.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-30005","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/30005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=30005"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/30005\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=30005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=30005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=30005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}